Efficacy of orlistat in non-alcoholic fatty liver disease: A ...

文章推薦指數: 80 %
投票人數:10人

In the studies analyzed, orlistat improved biochemical markers of liver disease. Orlistat treatment reduced the levels of ALT, AST and GGT compared to baseline in patients with NAFLD; however, the subgroup analysis did not reveal significant differences in patients with NASH.



請為這篇文章評分?